Safe and Affordable Drugs from Canada Act of 2017

Summary

Safe and Affordable Drugs from Canada Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that: is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA. Certain medications may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 9 March 2017

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 9 March 2017

   Introduced

   Introduced in House

   Source: IntroReferral

3. 9 March 2017

   Introduced

   Introduced in House

   Source: IntroReferral

4. 10 March 2017

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 9 March 2017 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 9 March 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 9 March 2017

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 9 March 2017

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Pingree, Chellie [D-ME-1] · D · Sponsor
• Rep. Cohen, Steve [D-TN-9] · D · Sponsor
• Rep. Lipinski, Daniel [D-IL-3] · D · Sponsor
• Rep. Slaughter, Louise McIntosh [D-NY-25] · D · Sponsor
• Rep. Garamendi, John [D-CA-8] · D · Cosponsor
• Rep. Lofgren, Zoe [D-CA-18] · D · Cosponsor
• Rep. Rohrabacher, Dana [R-CA-48] · R · Cosponsor
• Rep. Herrera Beutler, Jaime [R-WA-3] · R · Cosponsor
• Rep. Posey, Bill [R-FL-8] · R · Cosponsor
• Rep. Joyce, David P. [R-OH-14] · R · Cosponsor
• · hsif00 · Standing

Related records

• related to → Safe and Affordable Drugs from Canada Act of 2019
• related to → Safe and Affordable Drugs from Canada Act of 2017
• related to → Safe and Affordable Drugs from Canada Act of 2017
• related to ← Safe and Affordable Drugs from Canada Act of 2015